Search

Search 

People

...the investigation into breast cancer at the molecular...Andy joined the Breast Cancer Pathology Research Group...novel classification of breast cancer based on phenotypic...expertise is within breast cancer molecular pathology using

Staff listing for the Molecular Therapeutics and Formulation Division

...of triple negative breast cancer JOURNAL OF CONTROLLED...

Alan McIntyre

...Medical Research Council, Breast Cancer Now and Bowel & Cancer Research. I have...in triple negative breast cancer: Oncogene Oncogene. MCINTYRE...in triple negative breast cancer: Oncogene Oncogene. MCINTYRE

Stewart Martin

...2012' by the Breast Cancer Campaign. The TRBR...initiated the Nottingham Breast Cancer Research Centre (NBCRC...action of novel anticancer agents for the treatment of breast, brain and ovarian cancer; Redox regulation in breast, brain and ovarian cancer; The calpain and

People

...coding RNAs to cancer progression and metastasis...that lead to cancer progression and metastasis...and proteins, promotes cancer progression and the...primary and metastatic cancers of bone as...Human Triple Negative Breast Cancer Cells Biology. 10

Ruman Rahman

...to triple negative breast cancer models. Biomater. Sci...to Clinical Trials CANCERS. 15(3), MOLONEY...of triple negative breast cancers Biomaterials Science. 11

Steven Howdle

...of methotrexate in breast cancer cells BIOMATERIALS SCIENCE...

Staff listing for the Biomolecular Science and Medicinal Chemistry Division

...in the Human Breast, Prostate and Colorectal Cancer Cells Journal of Cancer Treatment and Research...6-Shogaol inhibits breast and colon cancer cell proliferation through...721648) sensitivity in breast and colorectal cancer cells. Molecular cancer therapeutics. 10(10...methylphenyl)benzothiazole in breast cancer cell lines Breast Cancer Research and Treatment

Ian Spendlove

...protein LIMD1 in breast cancer correlates with patient...

Andrew Jackson

...including malignant melanoma, breast cancer, brain tumours in...of tumours from breast cancer (UK patients and
431 to 440 of 1660